Cargando…
Rapid response to radiotherapy in unresectable tracheal adenoid cystic carcinoma: A case report
BACKGROUND: Adenoid cystic carcinoma (ACC) occurs mainly in the head and neck. Tracheal ACC (TACC) is uncommon. Primary resection is recommended as the main treatment of choice, and radiotherapy is considered for residual disease in the postoperative setting. Definitive radiotherapy is an alternativ...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610865/ https://www.ncbi.nlm.nih.gov/pubmed/34877287 http://dx.doi.org/10.12998/wjcc.v9.i31.9535 |
_version_ | 1784603179168563200 |
---|---|
author | Wu, Qiang Xu, Feng |
author_facet | Wu, Qiang Xu, Feng |
author_sort | Wu, Qiang |
collection | PubMed |
description | BACKGROUND: Adenoid cystic carcinoma (ACC) occurs mainly in the head and neck. Tracheal ACC (TACC) is uncommon. Primary resection is recommended as the main treatment of choice, and radiotherapy is considered for residual disease in the postoperative setting. Definitive radiotherapy is an alternative approach to cure unresectable TACC. As the status of radiosensitivity in TACC is uncertain, the evidence for radiotherapy in unresectable TACC is not well established, especially in terms of the optimal dosage and its response evaluation. Herein, we report a case of locally advanced TACC. CASE SUMMARY: A 49-year-old woman was diagnosed with TACC, which included a range of lesions arising in the upper trachea extending caudally 2 cm to 7 cm of the glottis. She was treated with definitive radiotherapy, given the low likelihood of complete resection of the disease. Due to the indolent growth and the propensity for infiltration along the airways, the scheduled radiation dose of 76 Gy in 38 fractions with 6-MV X-ray delivered by intensity-modulated radiotherapy was conducted to the primary tumor volume. After irradiation of 40 Gy, the patient’s dyspnea on exertion was dramatically relieved and bronchoscopy revealed that the previous large polypoid intra-luminal mass was significantly eliminated, with near-complete response. The patient completed two phases of scheduled radiotherapy, and acute reactions to treatment included subjective chest tightness and grade 2 esophagitis, managed medically. After 5 years of treatment, the patient is alive without recurrent disease, and there were no serious late radiation esophagus and lung damage, with only slight dysphagia without perforation and fistula. CONCLUSION: Taken together, TACC is uncommon and the treatment of unresectable TACC is challenging. This case indicated that patients with unresectable TACC who rapidly respond to radiation may benefit from primary radical radiotherapy. Radiotherapy may be considered an effective alternative treatment modality. |
format | Online Article Text |
id | pubmed-8610865 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-86108652021-12-06 Rapid response to radiotherapy in unresectable tracheal adenoid cystic carcinoma: A case report Wu, Qiang Xu, Feng World J Clin Cases Case Report BACKGROUND: Adenoid cystic carcinoma (ACC) occurs mainly in the head and neck. Tracheal ACC (TACC) is uncommon. Primary resection is recommended as the main treatment of choice, and radiotherapy is considered for residual disease in the postoperative setting. Definitive radiotherapy is an alternative approach to cure unresectable TACC. As the status of radiosensitivity in TACC is uncertain, the evidence for radiotherapy in unresectable TACC is not well established, especially in terms of the optimal dosage and its response evaluation. Herein, we report a case of locally advanced TACC. CASE SUMMARY: A 49-year-old woman was diagnosed with TACC, which included a range of lesions arising in the upper trachea extending caudally 2 cm to 7 cm of the glottis. She was treated with definitive radiotherapy, given the low likelihood of complete resection of the disease. Due to the indolent growth and the propensity for infiltration along the airways, the scheduled radiation dose of 76 Gy in 38 fractions with 6-MV X-ray delivered by intensity-modulated radiotherapy was conducted to the primary tumor volume. After irradiation of 40 Gy, the patient’s dyspnea on exertion was dramatically relieved and bronchoscopy revealed that the previous large polypoid intra-luminal mass was significantly eliminated, with near-complete response. The patient completed two phases of scheduled radiotherapy, and acute reactions to treatment included subjective chest tightness and grade 2 esophagitis, managed medically. After 5 years of treatment, the patient is alive without recurrent disease, and there were no serious late radiation esophagus and lung damage, with only slight dysphagia without perforation and fistula. CONCLUSION: Taken together, TACC is uncommon and the treatment of unresectable TACC is challenging. This case indicated that patients with unresectable TACC who rapidly respond to radiation may benefit from primary radical radiotherapy. Radiotherapy may be considered an effective alternative treatment modality. Baishideng Publishing Group Inc 2021-11-06 2021-11-06 /pmc/articles/PMC8610865/ /pubmed/34877287 http://dx.doi.org/10.12998/wjcc.v9.i31.9535 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
spellingShingle | Case Report Wu, Qiang Xu, Feng Rapid response to radiotherapy in unresectable tracheal adenoid cystic carcinoma: A case report |
title | Rapid response to radiotherapy in unresectable tracheal adenoid cystic carcinoma: A case report |
title_full | Rapid response to radiotherapy in unresectable tracheal adenoid cystic carcinoma: A case report |
title_fullStr | Rapid response to radiotherapy in unresectable tracheal adenoid cystic carcinoma: A case report |
title_full_unstemmed | Rapid response to radiotherapy in unresectable tracheal adenoid cystic carcinoma: A case report |
title_short | Rapid response to radiotherapy in unresectable tracheal adenoid cystic carcinoma: A case report |
title_sort | rapid response to radiotherapy in unresectable tracheal adenoid cystic carcinoma: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610865/ https://www.ncbi.nlm.nih.gov/pubmed/34877287 http://dx.doi.org/10.12998/wjcc.v9.i31.9535 |
work_keys_str_mv | AT wuqiang rapidresponsetoradiotherapyinunresectabletrachealadenoidcysticcarcinomaacasereport AT xufeng rapidresponsetoradiotherapyinunresectabletrachealadenoidcysticcarcinomaacasereport |